BCH4024 F24 OC E2MU 1024 Q30: Promising drugs have been deve…

BCH4024 F24 OC E2MU 1024 Q30: Promising drugs have been developed to treat invasive cancers. A class of these drugs act as competitive inhibitors of ATP binding to active sites of receptor tyrosine kinases (RTKs). What are some possible downstream effects of RTK activation in healthy cells?